Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gallwitz

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Journal of Molecular Endocrinology|August 1, 1990
Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cellsB Gallwitz, W E Schmidt, J M Conlon, et al.
International Journal of Clinical Practice|September 18, 2010
Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialB Göke, B Gallwitz, J Eriksson, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 26, 1998
Effect of human pancreastatin peptide (hP-16) on oral glucose tolerance in manE G Siegel, B Gallwitz, U R Fölsch, et al.
Diabetes, Obesity & Metabolism|October 9, 2012
Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitusW Kothny, J Foley, P Kozlovski, et al.
Diabetes, Obesity & Metabolism|July 23, 2008
Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trialA Liebl, R Prager, K Binz, et al.
Endocrinology|February 1, 1987
Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39W E Schmidt, E G Siegel, H Kümmel, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2010
Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegalyT Psaras, M Milian, V Hattermann, et al.
International Journal of Clinical Practice|March 26, 2013
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA₁c < 7% with no hypoglycaemia and no weight gain over 2 yearsB Gallwitz, J Rosenstock, A Emser, et al.
Journal of Molecular Endocrinology|June 1, 1993
Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cellsB Gallwitz, M Witt, U R Fölsch, et al.
Regulatory Peptides|December 30, 1986
Characterization of an amidated form of pancreatic polypeptide from the daddy sculpin (Cottus scorpius)J M Conlon, W E Schmidt, B Gallwitz, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Journal of Molecular Endocrinology|August 1, 1990
Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cellsB Gallwitz, W E Schmidt, J M Conlon, et al.
International Journal of Clinical Practice|September 18, 2010
Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialB Göke, B Gallwitz, J Eriksson, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 26, 1998
Effect of human pancreastatin peptide (hP-16) on oral glucose tolerance in manE G Siegel, B Gallwitz, U R Fölsch, et al.
Diabetes, Obesity & Metabolism|October 9, 2012
Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitusW Kothny, J Foley, P Kozlovski, et al.
Diabetes, Obesity & Metabolism|July 23, 2008
Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trialA Liebl, R Prager, K Binz, et al.
Endocrinology|February 1, 1987
Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39W E Schmidt, E G Siegel, H Kümmel, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 10, 2010
Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegalyT Psaras, M Milian, V Hattermann, et al.
International Journal of Clinical Practice|March 26, 2013
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA₁c < 7% with no hypoglycaemia and no weight gain over 2 yearsB Gallwitz, J Rosenstock, A Emser, et al.
Journal of Molecular Endocrinology|June 1, 1993
Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cellsB Gallwitz, M Witt, U R Fölsch, et al.
Regulatory Peptides|December 30, 1986
Characterization of an amidated form of pancreatic polypeptide from the daddy sculpin (Cottus scorpius)J M Conlon, W E Schmidt, B Gallwitz, et al.
Pageof 7